Martin Diggle

Co-Founder and Chairman of Vulpes Investment Management UK Ltd.

Martin, who Co-Founded Vulpes Investment Management, and is now the Chairman and director of the Vulpes Life Sciences fund has been a passionate and active investor, with over 20 years of experience in life sciences.

He has served on the Board of several public and privately listed companies within our portfolio, including Oxford Biomedica, Scancell, Proteome Sciences, Chronos, Leucid and Oxford Endovascular.

Over the years he has been a huge advocate and supporter of life sciences where he has contributed both his own capital and extensive business experience to ensure that these companies reach their full potential.

Prior to Vulpes Martin was a Partner and Director of UBS/Brunswick. Before that, he spent 7 years at Morgan Stanley. Martin graduated from the University of Oxford with a Masters in Philosophy, Politics and Economics.

Subscribe to our newsletter to receive our latest news and updates!